Physician Investment Group Finds Success with Its Portfolio of Companies
- Nasdaq eyes record closing high as Powell testimony looms
- Sanderson Farms (SAFM) Explores Sale - Report
- Bitcoin (BTC) Cracks $30,000 to Hit 6-Month Low, Here Are Next Targets Lower
- Dollar edges higher before Powell; Bitcoin drops
- Splunk (SPLK) Lands $1 Billion From Silver Lake, Announces Buyback One Day After Activist Rumors Surface
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
DAYTON, Ohio, Nov. 21, 2017 /PRNewswire/ -- Physician Investment Group, an investment fund founded by Dr Amol Soin, has found success in 2017. Soin, a practicing physician and researcher, has built a portfolio of mostly Ohio based biotechnology companies. In most instances, Soin has served as an active member on the Board of Directors, Clinical Advisory Board, or has been a co-inventor on multiple products in the portfolio. Physician Investment Group has provided angel/venture capital investment in all of their portfolio companies.
This year Physician Investment Group's portfolio of companies has started to mature. Neuros Medical, a Cleveland based Biotech company that is developing a platform technology to treat chronic pain, attracted a $20 million venture capital investment in 2017. Soin serves as Director of the Clinical Advisory Board and conducted Neuros' early clinical trial work for the first two in-human trials in Dayton, OH.
Thermalin, another Cleveland based Biotech company working on novel insulin molecules, has recently signed a deal with Sanofi that provided a $17.5 million venture investment and could generate up to $788 million for Thermalin, making it one of the largest research and development commitments for next-generation insulin.
China Rapid Finance, a peer to peer lending company, had an initial public offering (IPO) in April 2017 on Nasdaq this year raising approximately $60 million and it is currently trading at around 58% above the IPO price.
Another portfolio company, Soin Neuroscience, is developing a new nonnarcotic painkiller to treat diabetic neuropathy. They recently signed a licensing deal for one of its drugs which Soin is a co-inventor of, for milestone payments of $225 million and an additional 7.5% royalty. Soin Neuroscience has many other patents and products in development with various mechanisms of action to treat disease states such as chronic pain, post stroke syndrome, and intensive care unit myopathy. Soin Neuroscience also provides clinical trial services through its research lab in Centerville, OH oftentimes partnering with other large biotech companies to complete clinical trial work for those larger companies.
About Physician Investment Group:
Physician Investment Group is an investment fund started by Dr Amol Soin, got its name because Dr Soin is a physician who has made early stage investments in a group of companies. Dr Soin takes an active role in the portfolio companies they invest in. For further information contact: Amol Soin at email@example.com
CONTACT: Amol Soin, firstname.lastname@example.org
View original content with multimedia:http://www.prnewswire.com/news-releases/physician-investment-group-finds-success-with-its-portfolio-of-companies-300560008.html
SOURCE Soin Neuroscience
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- F45 Training Holdings (FXLV) Files a Proposed $100M IPO
- BLACK ENTERPRISE to Present Its Second Groundbreaking Summit Bringing Together Top Leaders in Diversity, Equity, and Inclusion, June 23
- TidalScale Announces Reseller Agreement with 365 Master Data
Create E-mail Alert Related CategoriesPress Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!